![Rod Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 122 M $ in data 30/06/2026
Roderick Tze Ian Wong is the founder of RTW Investments LP, founded in 2010, where the title held is Managing Partner & Chief Investment Officer.
Current jobs include Director at Rocket Pharmaceuticals, Inc. since 2018, Director at Attune Pharmaceuticals, Inc. since 2018, Director at NiKang Therapeutics, Inc. since 2020, and Managing Partner & Chief Investment Officer at RTW Investments LP since 2009.
Former jobs include Chairman, President & Chief Executive Officer at Health Sciences Acquisitions Corp.
from 2018 to 2019; Chairman at Rocket Pharmaceuticals Ltd. from 2015 to 2018; Director at Health Sciences Acquisitions Corp.
2; Director at Penwest Pharmaceuticals Co. in 2010; Independent Director at Avidity Biosciences, Inc. from 2019 to 2021; Independent Director at Landos Biopharma, Inc. from 2019 to 2022; Director at CORXEL Pharmaceuticals (Shanghai) Co., Ltd.; Research Associate at Cowen & Co. (New York); and Principal at Davidson Kempner Capital Management LP.
Education includes undergraduate degree from Duke University, doctorate from Perelman School of Medicine, and MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RTW Biotech Opportunities Ltd.
 RTW Biotech Opportunities Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a venture capital fund 15,34% | 27/03/2025 | 50.356.880 ( 15,34% ) | 122 M $ | 30/06/2026 |
| 18/06/2026 | 75.499 ( 0,07% ) | 258 207 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Direttore/Membro del Consiglio | 01/09/2020 |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Direttore degli Investimenti | - |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW aims to generate attractive risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the healthcare sector. The Funds primarily invest in the equity and debt of public and private issuers globally, with a focus on the US and Europe. Derivatives are employed to improve payoff structures, as well as to construct hedges. | Amministratore Delegato | 01/02/2010 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Direttore/Membro del Consiglio | 01/06/2018 |
| Società | Posizione | Fine |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Direttore/Membro del Consiglio | 07/06/2022 |
| AVIDITY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 25/08/2021 |
| IMMUNOVANT, INC. | Amministratore Delegato | 01/12/2019 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Presidente | 01/01/2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Cowen & Co. (New York)
 Cowen & Co. (New York) Investment Banks/BrokersFinance Provides security brokerage services | Finance |
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance DKCM invests client assets using a variety of arbitrage and other event-driven strategies, including risk arbitrage transactions and investments in financially distressed companies. The firm's primary investment strategies include distressed investing, mergers and acquisitions (or risk) arbitrage, long/short equities, and convertible and volatility arbitrage. As distressed investment opportunities are identified, they are subjected to rigorous, fundamental, bottom-up analysis. | Finance |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
RTW Investments LP
RTW Investments LP Investment ManagersFinance RTW aims to generate attractive risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the healthcare sector. The Funds primarily invest in the equity and debt of public and private issuers globally, with a focus on the US and Europe. Derivatives are employed to improve payoff structures, as well as to construct hedges. | Finance |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Health Technology |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Commercial Services |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Finance |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Health Technology |
Health Sciences Acquisitions Corp. 2
 Health Sciences Acquisitions Corp. 2 Financial ConglomeratesFinance Operates as a blank check company | Finance |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
